Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELICO: IV Lidocaine in ENT Surgery
NCT02894710Phase 3Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Dec 2016
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Lidocaine with Placebo (2 arms). Primary endpoint: Total morphine requirement during the first 48 postoperative hours at 48 hours. Started Dec 2016; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02894710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02894710.